Search Results 1731-1740 of 19973 for Receptor
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds. Joe Dangor. February 19, 2019.
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...
This disorder includes nervous system symptoms affecting movement or the senses that are not caused by medical disease. Treatment can help with recovery.
- Receipt of chimeric antigen receptor T-cell (CAR-T) therapy. - Received a fecal microbiota transplant (FMT) or any live microbial therapeutic within 3 ...
Asthma (history of physician diagnosis of asthma + on asthma controller medication [eg, inhaled corticosteroid, leukotriene receptor antagonist]. Currently ...
And then they become larger. And when those blood vessels rapidly change size like that, it activates the pain receptors.” These blasts typically last only a ...
The purpose of this study is to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.
Anti-seizure drugs designed to treat epilepsy often are used to control nerve pain associated with diabetes, shingles, and other types of nerve damage.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.